Execution is becoming a product layer
Research agents are increasingly connecting literature, hypothesis generation, computational tools, CROs, and automated laboratories rather than stopping at text generation.
Market structure
What is changing
The field is moving from general-purpose scientific chat toward specialized, executable, institutionally embedded systems.
Domain stacks are separating from general agents
Chemistry, materials, biomedicine, evidence synthesis, and publication integrity are developing distinct products with specialized data, tools, and validation requirements.
Scientific memory is moving inside institutions
Enterprise platforms are combining internal experiments, documents, knowledge graphs, and external evidence to support organizational rather than individual workflows.
Trust infrastructure remains fragmented
Evidence grading, reproducibility checks, image integrity, statistical verification, peer review, and regulatory translation still sit in separate systems.
Full research lifecycle
Workflow map
Select a stage to filter the company landscape below.
Competitive landscape
Landscape explorer
Compare positioning, workflow coverage, maturity, and competitive edge across the mapped ecosystem.
31 organizations shown
KD
K-Dense
Company / product · Emerging scale-up
Agentic research and execution orchestration
- Competitive edge
- Workflow depth + execution partners
- Landscape note
- Hypothesis-to-experiment orchestration; comparative benchmark is vendor-run.
Discovery & literature groundingSummary & synthesisExperiment designExecution / lab translation
TS
Traverse Science
Company · Emerging
Scientific fact-checking and translation
- Competitive edge
- Domain expertise + trusted interpretation
- Landscape note
- Cross-workflow translation and evidence-quality layer; classification currently rests mainly on the official site.
Discovery & literature groundingSummary & synthesisAuthoringTrusted evidence generationPeer reviewClinical / regulatory translation
CS
Claude Science
Product / workflow · Public beta
General scientific workbench
- Competitive edge
- Foundation model + tools + compute + audit trails
- Landscape note
- Officially launched June 30, 2026 as an AI workbench for scientists.
Discovery & literature groundingSummary & synthesisAuthoringSubmission readinessExperiment designExecution / lab translation
P
Potato
Company · Emerging
Closed-loop scientific planning and lab execution
- Competitive edge
- Structured experiment models + lab translation
- Landscape note
- Official pages support experiment design, protocol generation, automation-ready outputs, analysis, and iteration.
Discovery & literature groundingSummary & synthesisExperiment designExecution / lab translationTrusted evidence generation
R
Reviewer3
Company / product · Emerging
Submission readiness and AI peer review
- Competitive edge
- Multi-agent manuscript review + journal workflow
- Landscape note
- Product now explicitly addresses researchers, journals, and institutions; vendor benchmark remains conflicted evidence.
Summary & synthesisAuthoringSubmission readinessTrusted evidence generationPeer review
C
Consensus
Company / product · Growth
Evidence search and literature grounding
- Competitive edge
- Evidence-focused UX + corpus indexing
- Landscape note
- July 2026 changelog verifies expanded methodology, publisher, and setting filters.
Discovery & literature groundingSummary & synthesisTrusted evidence generation
E
Elicit
Company / product · Growth
Literature review and evidence synthesis
- Competitive edge
- Structured extraction + review workflows
- Landscape note
- Core evidence-synthesis competitor. No specific dated update was asserted in this audit.
Discovery & literature groundingSummary & synthesisAuthoringTrusted evidence generation
S
Scite
Company / product · Established
Citation context and evidence grounding
- Competitive edge
- Smart-citation graph
- Landscape note
- Citation provenance and claim-context infrastructure.
Discovery & literature groundingSummary & synthesisAuthoringTrusted evidence generationPeer review
BE
BenchSci EMET
Company / product · Scale-up
Enterprise scientific memory and preclinical R&D
- Competitive edge
- Private data + knowledge graph + enterprise deployment
- Landscape note
- Official product sources support internal-data reasoning and self-driving-lab connectivity; performance claims remain vendor-authored.
Discovery & literature groundingSummary & synthesisExperiment designExecution / lab translationTrusted evidence generationClinical / regulatory translation
SB
Schrodinger Bunsen
Product · Early access
Chemistry-native agentic co-scientist
- Competitive edge
- Computational chemistry stack + executable tools
- Landscape note
- Officially announced July 27, 2026.
Discovery & literature groundingSummary & synthesisExperiment designExecution / lab translationTrusted evidence generationClinical / regulatory translation
FE
FutureHouse / Robin
Nonprofit / company / product · Emerging
Autonomous scientific research agents
- Competitive edge
- Purpose-built agents + scientific tooling
- Landscape note
- Peer-reviewed Nature paper supports a multi-agent automated discovery system; generalization beyond tested settings remains open.
Discovery & literature groundingSummary & synthesisAuthoringExperiment designExecution / lab translationTrusted evidence generation
LS
Litmus Science
Company · Emerging
Outsourced experimental execution marketplace
- Competitive edge
- Laboratory network + experiment coordination
- Landscape note
- K-Dense partnership announcement provides direct workflow evidence.
Experiment designExecution / lab translationTrusted evidence generation
LS
Lila Sciences
Company · Scale-up
AI science factory and autonomous experimentation
- Competitive edge
- Closed-loop labs + proprietary experimental data
- Landscape note
- Officially reports three DOE Genesis Mission Phase I awards.
Discovery & literature groundingSummary & synthesisExperiment designExecution / lab translationTrusted evidence generationClinical / regulatory translation
C
CuspAI
Company · Scale-up
AI materials discovery and industrial translation
- Competitive edge
- Materials models + industrial network + validation
- Landscape note
- Foundry is corroborated by partner institutions. Funding round is secondary-reported; current official site reports cumulative funding separately.
Discovery & literature groundingSummary & synthesisExperiment designExecution / lab translationTrusted evidence generationProductionClinical / regulatory translation
O
OpenEvidence
Company / product · Growth
Clinical evidence interface and translation
- Competitive edge
- Clinical corpus + institutional distribution + trust layer
- Landscape note
- EvidenceGrade and multiple partnerships are verified, but independent calibration of EvidenceGrade remains a gap.
Discovery & literature groundingSummary & synthesisAuthoringTrusted evidence generationClinical / regulatory translation
IM
Insilico Medicine
Company · Established scale-up
AI drug discovery and regulated translation
- Competitive edge
- Integrated discovery platform + proprietary assets + trials
- Landscape note
- Phase III initiation is verified. The prior ISM6331 Fast Track claim was removed as unverified.
Discovery & literature groundingSummary & synthesisExperiment designExecution / lab translationTrusted evidence generationProductionClinical / regulatory translation
BA
Bibby AI
Company / product · Emerging
Research-write-publish environment
- Competitive edge
- Editor-native integrated workflow
- Landscape note
- Product and preprint support the classification; adoption figures are self-reported.
Discovery & literature groundingSummary & synthesisAuthoringSubmission readinessPeer reviewProduction
R
ReviewerZero
Company / product · Emerging
Research integrity and deterministic manuscript checks
- Competitive edge
- Recomputation + integrity checks + publisher integration
- Landscape note
- Official platform describes statistics, image, reference, identity, replicability, and peer-review checks.
Submission readinessTrusted evidence generationPeer reviewProduction
S
SciScore
Company / product · Established
Rigor, transparency, and methods reporting checks
- Competitive edge
- Structured compliance and reproducibility checks
- Landscape note
- Deterministic and policy-facing publication-integrity layer.
Submission readinessTrusted evidence generationPeer reviewProduction
D
DataSeer
Company / product · Growth
Data and code availability review
- Competitive edge
- Research output detection + publisher integration
- Landscape note
- Specialized data-sharing and reproducibility screening.
Submission readinessTrusted evidence generationPeer reviewProduction
P
Proofig
Company / product · Growth
Scientific image integrity
- Competitive edge
- Image forensics + editorial workflow
- Landscape note
- Specialized image-integrity screening.
Submission readinessTrusted evidence generationPeer reviewProduction
I
ImageTwin
Company / product · Growth
Scientific image duplication detection
- Competitive edge
- Large comparison corpus + image similarity
- Landscape note
- Niche image-integrity infrastructure.
Submission readinessTrusted evidence generationPeer reviewProduction
P
Paperpal
Company / product · Growth
Academic writing and submission readiness
- Competitive edge
- Author distribution + language/editor workflow
- Landscape note
- Authoring and submission-readiness competitor.
AuthoringSubmission readinessProduction
W
Writefull
Company / product · Established
Academic language and writing assistance
- Competitive edge
- Academic-language models + publisher integrations
- Landscape note
- Author and publisher writing support.
AuthoringSubmission readinessProduction
T
Trinka
Company / product · Growth
Academic and technical writing assistance
- Competitive edge
- Language tooling + submission checks
- Landscape note
- Authoring and readiness layer.
AuthoringSubmission readinessProduction
EM
Editorial Manager
Publishing infrastructure · Established
Submission and peer-review management
- Competitive edge
- Publisher integrations + workflow lock-in
- Landscape note
- Core publication-process infrastructure rather than an AI-native science company.
Submission readinessPeer reviewProduction
O
OpenReview
Nonprofit platform · Established
Open peer review and publication workflow
- Competitive edge
- Community adoption + open review data
- Landscape note
- Important peer-review infrastructure and benchmark data source.
Submission readinessPeer reviewProduction
N
NewsGuard
Company / product · Established
Trust data, fact-checking, and trusted-answer interface
- Competitive edge
- Journalist-vetted source graph + distribution
- Landscape note
- Direct answer product launched June 23, 2026, not July.
Discovery & literature groundingSummary & synthesisTrusted evidence generationClinical / regulatory translation
D
DeepEvidence
Research system · Published research
Biomedical evidence exploration and synthesis
- Competitive edge
- Evidence graph + biomedical KG tooling
- Landscape note
- Peer-reviewed system, not currently classified as a standalone company.
Discovery & literature groundingSummary & synthesisExperiment designTrusted evidence generationClinical / regulatory translation
C
Clarivate
Company / infrastructure · Established
Research intelligence and publishing infrastructure
- Competitive edge
- Proprietary indices + institutional distribution
- Landscape note
- Broad infrastructure incumbent spanning discovery, analytics, and publishing.
Discovery & literature groundingSummary & synthesisSubmission readinessTrusted evidence generationPeer reviewProductionClinical / regulatory translation
DS
Digital Science
Company / portfolio · Established
Research workflow, analytics, and publishing infrastructure
- Competitive edge
- Portfolio breadth + institutional integrations
- Landscape note
- Portfolio-level competitor across research lifecycle infrastructure.
Discovery & literature groundingSummary & synthesisAuthoringSubmission readinessTrusted evidence generationPeer reviewProductionClinical / regulatory translation
No organizations match these filters.
Launches, funding, partnerships, and evidence
Recent developments
Each item links directly to the relevant announcement, publication, filing, partner release, or reporting.
25 developments shown
2026-07-29
OpenAI academic access program
MediumAxios reported a program offering up to 100,000 academic researchers free access to advanced ChatGPT models through 2027.
Evidence context
No matching official OpenAI announcement was located during this audit; retain as secondary reporting only.
2026-07-27
Schrodinger Bunsen
HighSchrodinger announced early access to Bunsen, an agentic co-scientist for molecular discovery.
Evidence context
Launch announcement does not establish comparative effectiveness.
2026-07-23
K-Dense + Litmus Science
HighAnnounced a partnership intended to connect AI research workflows with outsourced physical experiments.
Evidence context
The integrated workflow is described as in progress; performance and adoption are not independently established.
2026-07-23
OpenEvidence + LA County DPH
MediumLA County Public Health announced a collaboration to surface local public-health guidance in selected clinical searches.
Evidence context
The partners plan evaluation; results were not yet reported.
2026-07-22
Lila Sciences
HighLila reported selection for three DOE Genesis Mission Phase I awards with national-lab and university partners.
Evidence context
Award selection validates participation, not downstream scientific outcomes.
2026-07-22
OpenAI + DOE Genesis
HighOpenAI announced Codex/API support and scientific-program commitments for DOE Genesis researchers and campaigns.
Evidence context
Commitments and access are verified; scientific outcomes are future-facing.
2026-07-20
CuspAI
HighLaunched/expanded the AI Materials Foundry, a network spanning data, compute, laboratories, and industrial partners.
Evidence context
Official site currently reports more than 45 partners; exact partner count may change.
2026-07-20
CuspAI
HighIndependent reporting described a roughly $450 million funding round at a roughly $2.6 billion valuation.
Evidence context
Do not confuse the round size with the cumulative amount raised; CuspAI's current site reports cumulative funding above $650 million.
2026-07-16
K-Dense vs Claude Science
MediumK-Dense published a 20-task comparison reporting stronger execution packaging for K-Dense and slightly higher scientific-quality scores for Claude Science.
Evidence context
Produced by K-Dense, platform identity visible, one judge family, and not independent validation.
2026-07-15
OpenEvidence + AAP
HighAAP confirmed that its research, policies, recommendations, and publications would inform OpenEvidence responses.
Evidence context
Partnership scope does not itself validate answer accuracy.
2026-07-14
BenchSci EMET
HighBenchSci announced that EMET can reason over internal documents, ELNs, reports, and experimental databases alongside external evidence.
Evidence context
Product and efficiency claims are vendor-authored.
2026-07-14
BOSC 2026
MediumBOSC reported AI-assisted evidence gathering for openness, licensing, and runnability while humans retained every acceptance decision.
Evidence context
Reviewers preferred to verify conclusions themselves, supporting bounded rather than autonomous use.
2026-07-10
OpenEvidence
HighOpenEvidence launched EvidenceGrade to display its assessment of the strength/quality of evidence supporting answers.
Evidence context
The launch source is company-authored; independent calibration, agreement, and decision-impact validation remain open.
2026-07-09
BenchSci
MediumBenchSci appointed former Pfizer R&D chief Mikael Dolsten as its first board chair.
Evidence context
Strategic signal, not product-performance evidence.
2026-07-09
OpenEvidence + NYP/Columbia/Weill Cornell
HighNewYork-Presbyterian announced an enterprise-scale deployment with affiliated medical schools.
Evidence context
Deployment scale is not equivalent to clinical-outcome evidence.
2026-07-08
Consensus
MediumConsensus expanded advanced search filters to 19 study designs, 44 publishers, and human/animal settings.
Evidence context
Feature availability is verified; effects on review quality or efficiency are not.
2026-07-07
Insilico Medicine
HighInsilico announced initiation of a Phase III trial for rentosertib in idiopathic pulmonary fibrosis.
Evidence context
Trial initiation is a translational milestone, not evidence of efficacy or approval.
2026-07-03
Bibby AI
MediumA company-authored preprint described an editor-native Research-Write-Publish architecture and self-reported adoption.
Evidence context
Adoption and time-savings claims are not independently validated.
2026-07-02
DeepEvidence
HighNature Machine Intelligence published DeepEvidence, a multi-agent biomedical evidence exploration and synthesis system with an evidence graph.
Evidence context
Benchmark results are stronger evidence than vendor claims, but external replication and real-world outcome studies remain important.
2026-06-30
Claude Science
HighAnthropic launched Claude Science in beta as an AI workbench integrating scientific tools, compute, artifacts, and audit history.
Evidence context
Capabilities are vendor-described; independent task-level evaluation is still limited.
2026-06-23
NewsGuard AI
MediumNewsGuard launched a consumer-facing chatbot constrained to journalist-vetted sources and designed to compensate cited publishers.
Evidence context
Trust-source curation is clear; answer-quality and neutrality claims still require independent evaluation.
2026-06-11
2026-05-19
FutureHouse / Robin
HighNature published a peer-reviewed multi-agent system for automating scientific discovery associated with FutureHouse/Edison researchers.
Evidence context
A research publication is not a blanket validation of the commercial platform or every domain.
2026-04-15
AAAI-26 AI review pilot
HighA preprint reported clearly labelled AI reviews for 22,977 full-review submissions generated in less than a day, with favorable participant ratings on several dimensions.
Evidence context
Preference/usefulness evidence does not establish editorial decision validity, robustness, or long-term effects.
2025-07-04
Logically
MediumLogically entered administration; reporting states that core technology, brand, and key assets transferred to Kreatur, while the brand and services continued.
Evidence context
The correct classification is not a simple shutdown or disappearance. Track predecessor company status and successor brand continuity separately.
No developments match these filters.
Unmet needs
Strategic gap analysis
The largest white spaces sit between workflow layers rather than inside any single point solution.
End-to-end provenance
Few systems preserve a machine-readable chain from source claim through analysis, experiment, manuscript, review, and translation.
Open opportunityA claim graph with immutable source/version IDs, transformation logs, and decision lineage.
Independent scientific-agent benchmarks
Many comparisons are vendor-run, use visible platform identity, static tasks, or LLM judges.
Open opportunityHidden fresh tasks, executable environments, preregistered scoring, blinded domain experts, and replication.
Protocol-to-publication consistency
Registration, protocol, analysis plan, manuscript, and supplement are rarely compared automatically.
Open opportunityA deterministic + model-assisted discrepancy engine with severity and provenance.
Evidence-grade calibration
Displaying a grade is not the same as demonstrating agreement, stability, calibration, or better decisions.
Open opportunityExternal GRADE-trained adjudication, repeated-question stability tests, and decision-impact studies.
Lab interoperability
Agents, CROs, robotic labs, ELNs, and instruments lack shared execution/provenance schemas.
Open opportunityOpen protocol, constraint, QC, result, and failure-return standards.
Adversarial peer-review evaluation
AI reviewers can be manipulated by presentation, laundering, prompt injection, prestige, and correlated judgments.
Open opportunityRolling contamination-resistant benchmarks and bounded deployment standards.
Outcome evidence
Speed, citations, and generated artifacts are intermediate outcomes.
Open opportunityProspective studies of reproducibility, candidate quality, clinical/industrial outcomes, and total cost.
Public evidence base
Reference library
Search the sources underlying company classifications and dated developments.
60 linked sources
| Source | Date | Source type | Evidence class | Supports |
|---|---|---|---|---|
| K-Dense | AI Agents for Real Research K-Dense | Official product/site | Primary | ORG:K-Dense | |
| Traverse Science Traverse Science | Official site | Primary | ORG:Traverse Science | |
| Claude Science, an AI workbench for scientists, is now available Anthropic | 2026-06-30 | Official product announcement | Primary | E001; ORG:Claude Science |
| Technology | Potato Potato | Official product page | Primary | ORG:Potato | |
| Reviewer3: AI Peer Review Reviewer3 | Official product page | Primary | E020; ORG:Reviewer3 | |
| Consensus Consensus | Official product/site | Primary | ORG:Consensus | |
| Elicit Elicit | Official product/site | Primary | ORG:Elicit | |
| Scite Scite | Official product/site | Primary | ORG:Scite | |
| Platform | BenchSci BenchSci | Official product page | Primary | ORG:BenchSci EMET | |
| Schrodinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery Schrodinger | 2026-07-27 | Official press release | Primary | E004; ORG:Schrodinger Bunsen |
| FutureHouse FutureHouse | Official site | Primary | ORG:FutureHouse / Robin | |
| Litmus Science Litmus Science | Official site | Primary | ORG:Litmus Science | |
| Lila Sciences Lila Sciences | Official site | Primary | ORG:Lila Sciences | |
| CuspAI | AI-powered materials discovery CuspAI | Official product/site | Primary | E006; ORG:CuspAI | |
| OpenEvidence OpenEvidence | Official product/site | Primary | ORG:OpenEvidence | |
| Insilico Medicine Insilico Medicine | Official site | Primary | ORG:Insilico Medicine | |
| Bibby AI - AI LaTeX Editor for Researchers Bibby AI | Official product page | Primary | ORG:Bibby AI | |
| ReviewerZero AI ReviewerZero | Official product page | Primary | E021; ORG:ReviewerZero | |
| SciScore SciScore | Official product/site | Primary | ORG:SciScore | |
| DataSeer DataSeer | Official product/site | Primary | ORG:DataSeer | |
| Proofig Proofig | Official product/site | Primary | ORG:Proofig | |
| ImageTwin ImageTwin | Official product/site | Primary | ORG:ImageTwin | |
| Paperpal Paperpal | Official product/site | Primary | ORG:Paperpal | |
| Writefull Writefull | Official product/site | Primary | ORG:Writefull | |
| Trinka Trinka | Official product/site | Primary | ORG:Trinka | |
| Editorial Manager Aries Systems | Official product page | Primary | ORG:Editorial Manager | |
| OpenReview OpenReview | Official platform | Primary | ORG:OpenReview | |
| NewsGuard NewsGuard | Official site | Primary | ORG:NewsGuard | |
| Empowering biomedical evidence exploration and synthesis with deep knowledge graph research Nature Machine Intelligence | 2026-07-02 | Peer-reviewed paper | Independent/peer-reviewed | E017; ORG:DeepEvidence |
| Clarivate Clarivate | Official site | Primary | ORG:Clarivate | |
| Digital Science Digital Science | Official site | Primary | ORG:Digital Science | |
| K-Dense Web and Litmus Science: Closing the Loop from Hypothesis to Experiment K-Dense | 2026-07-23 | Official partnership announcement | Primary/vendor-authored | E002; ORG:K-Dense; ORG:Litmus Science |
| K-Dense Web vs. Claude Science: K-Dense Leads on Execution and Overall Score K-Dense | 2026-07-16 | Vendor-run benchmark | Primary/conflicted | E003; ORG:K-Dense |
| Powering American Science: LILA to join DOE's Genesis Mission Lila Sciences | 2026-07-22 | Official award/partnership announcement | Primary | E005; ORG:Lila Sciences |
| Department of Materials Science & Metallurgy joins the founding lab network of CuspAI's AI Materials Foundry University of Cambridge | 2026-07-23 | Partner institution announcement | Independent partner | E006; ORG:CuspAI |
| Jeff Bezos and UK government invest in £2bn British startup CuspAI The Guardian | 2026-07-20 | News report | Independent secondary | E007; ORG:CuspAI |
| Imperial expert leads science at £2 billion AI materials company CuspAI Imperial College London | 2026-07-21 | University news | Independent partner | E007; ORG:CuspAI |
| EMET now reasons over your own data BenchSci | 2026-07-14 | Official product update | Primary/vendor-authored | E008; ORG:BenchSci EMET |
| BenchSci Names Former Pfizer R&D Chief Dr. Mikael Dolsten as Chairman of the Board BenchSci | 2026-07-09 | Official appointment announcement | Primary | E009; ORG:BenchSci EMET |
| OpenEvidence Launches EvidenceGrade PR Newswire / OpenEvidence | 2026-07-10 | Company press release | Primary/vendor-authored | E010; ORG:OpenEvidence |
| AAP research, policies and more added to OpenEvidence AI platform for physicians American Academy of Pediatrics | 2026-07-15 | Partner organization news | Independent partner | E011; ORG:OpenEvidence |
| OpenEvidence and NewYork-Presbyterian, Columbia University and Weill Cornell Medicine Expand Clinical AI Tools NewYork-Presbyterian | 2026-07-09 | Partner institution announcement | Independent partner | E012; ORG:OpenEvidence |
| Los Angeles County Department of Public Health and OpenEvidence Partner Los Angeles County Department of Public Health | 2026-07-23 | Government press release | Independent public authority | E013; ORG:OpenEvidence |
| Insilico Initiates Phase III Clinical Trial for Rentosertib Insilico Medicine | 2026-07-07 | Official clinical milestone announcement | Primary/vendor-authored | E014; ORG:Insilico Medicine |
| Exclusive: OpenAI offers 100,000 academics free ChatGPT access Axios | 2026-07-29 | News report | Independent secondary | E015 |
| Advancing the next era of national science OpenAI | 2026-07-22 | Official program announcement | Primary | E016 |
| Consensus Product Changelog Consensus Help Center | 2026-07-08 | Official product changelog | Primary | E018; ORG:Consensus |
| Bibby AI: An Editor-Native Agentic Platform for Academic Research, Writing, and Publishing arXiv | 2026-07-03 | Company-authored preprint | Primary/self-reported | E019; ORG:Bibby AI |
| Benchmarks - Reviewer3 Reviewer3 | Vendor benchmark page | Primary/conflicted | E020; ORG:Reviewer3 | |
| Platform | ReviewerZero AI ReviewerZero | Official product page | Primary/vendor-authored | E021; ORG:ReviewerZero | |
| AI-Assisted Peer Review at Scale: The AAAI-26 AI Review Pilot arXiv | 2026-04-15 | Conference field experiment preprint | Research/preprint | E022 |
| AI-assisted pre-review of open-source software submissions: an experience report from BOSC 2026 arXiv | 2026-07-14 | Experience report preprint | Research/preprint | E023 |
| No Hidden Prompts Needed! You Can Game AI Peer Review with Presentation-Only Revisions arXiv | 2026-06-11 | Robustness research preprint | Research/preprint | E024 |
| Stop Automating Peer Review Without Rigorous Evaluation arXiv | 2026-05-04 | Position/empirical preprint | Research/preprint | E024 |
| NewsGuard Launches First AI Chatbot Built to Deliver Trusted Journalism Only from Reliable News Websites NewsGuard | 2026-06-23 | Official product announcement | Primary/vendor-authored | E025; ORG:NewsGuard |
| THELOGICALLY LTD overview UK Companies House | Government corporate registry | Primary public record | E026 | |
| Britain's biggest fact-checking company goes into administration The Times | 2025-07-04 | News report | Independent secondary | E026 |
| A multi-agent system for automating scientific discovery Nature | 2026-05-19 | Peer-reviewed paper | Independent/peer-reviewed | E027; ORG:FutureHouse / Robin |
| Company | Potato Potato | Official company page | Primary/vendor-authored | ORG:Potato | |
| The Fragmented Nightmare of Modern Drug Discovery Ends Here: EMET launch BenchSci | 2026-06-08 | Official product launch | Primary/vendor-authored | ORG:BenchSci EMET |